Valencia Nutrition Ltd
Incorporated in 2013, Valencia Nutrition Ltd is in the business of developing, manufacturing, sales & distribution of nutraceutical products[1]
- Market Cap ₹ 126 Cr.
- Current Price ₹ 73.0
- High / Low ₹ 97.1 / 35.8
- Stock P/E 43.7
- Book Value ₹ 21.9
- Dividend Yield 0.00 %
- ROCE 5.85 %
- ROE 6.20 %
- Face Value ₹ 10.0
Pros
Cons
- Stock is trading at 3.34 times its book value
- Company has high debtors of 279 days.
- Working capital days have increased from 385 days to 734 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Fast Moving Consumer Goods Fast Moving Consumer Goods Beverages Other Beverages
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.07 | 0.39 | 0.73 | 0.41 | 1.42 | 2.37 | 0.95 | 0.00 | 1.46 | 1.34 | 8.47 | 10.55 | |
| 0.51 | 1.32 | 1.61 | 2.16 | 1.50 | 3.58 | 6.54 | 3.81 | 0.58 | 2.65 | 2.95 | 7.70 | 7.45 | |
| Operating Profit | -0.51 | -1.25 | -1.22 | -1.43 | -1.09 | -2.16 | -4.17 | -2.86 | -0.58 | -1.19 | -1.61 | 0.77 | 3.10 |
| OPM % | -1,785.71% | -312.82% | -195.89% | -265.85% | -152.11% | -175.95% | -301.05% | -81.51% | -120.15% | 9.09% | 29.38% | ||
| 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.08 | 0.00 | -0.49 | 0.00 | 0.00 | 0.31 | 0.65 | 0.34 | |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.04 | 0.09 | 0.01 | 0.00 | 0.03 | 0.13 | 0.15 |
| Depreciation | 0.01 | 0.04 | 0.04 | 0.04 | 0.06 | 0.06 | 0.12 | 0.13 | 0.08 | 0.07 | 0.05 | 0.21 | 0.41 |
| Profit before tax | -0.52 | -1.29 | -1.26 | -1.46 | -1.16 | -2.14 | -4.33 | -3.57 | -0.67 | -1.26 | -1.38 | 1.08 | 2.88 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| -0.52 | -1.29 | -1.26 | -1.47 | -1.16 | -2.14 | -4.34 | -3.58 | -0.66 | -1.26 | -1.38 | 1.07 | 2.88 | |
| EPS in Rs | -129.00 | -126.00 | -29.40 | -19.33 | -30.57 | -3.10 | -2.56 | -0.47 | -0.90 | -0.99 | 0.63 | 1.70 | |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 62% |
| 5 Years: | 29% |
| 3 Years: | % |
| TTM: | 371% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 18% |
| 3 Years: | 54% |
| TTM: | 240% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 27% |
| 3 Years: | 84% |
| 1 Year: | 29% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 6% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.02 | 0.04 | 0.06 | 0.19 | 0.25 | 0.28 | 5.59 | 5.59 | 5.59 | 5.59 | 5.59 | 16.98 | 16.98 |
| Reserves | 0.05 | 0.29 | 0.15 | -1.22 | 0.87 | 0.38 | -0.75 | -4.33 | -4.99 | -6.25 | -7.64 | 19.60 | 20.15 |
| 0.08 | 0.08 | 0.08 | 0.99 | 0.18 | 0.18 | 0.65 | 0.56 | 0.60 | 2.18 | 5.34 | 1.49 | 7.52 | |
| 0.08 | 0.10 | 0.23 | 0.37 | 0.32 | 0.57 | 1.32 | 1.86 | 1.24 | 1.26 | 2.71 | 0.35 | 0.20 | |
| Total Liabilities | 0.23 | 0.51 | 0.52 | 0.33 | 1.62 | 1.41 | 6.81 | 3.68 | 2.44 | 2.78 | 6.00 | 38.42 | 44.85 |
| 0.04 | 0.06 | 0.08 | 0.09 | 0.09 | 0.11 | 1.44 | 1.41 | 0.22 | 0.15 | 2.32 | 6.19 | 4.52 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 11.81 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.93 | 0.93 |
| 0.19 | 0.45 | 0.44 | 0.24 | 1.53 | 1.30 | 5.34 | 2.27 | 2.22 | 2.63 | 3.68 | 29.30 | 27.59 | |
| Total Assets | 0.23 | 0.51 | 0.52 | 0.33 | 1.62 | 1.41 | 6.81 | 3.68 | 2.44 | 2.78 | 6.00 | 38.42 | 44.85 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00 | -1.23 | -1.12 | -1.28 | -2.56 | -4.10 | -2.49 | -1.35 | -1.55 | -0.76 | -19.44 | |
| 0.00 | 0.00 | -0.06 | -0.05 | -0.05 | -0.01 | -2.05 | -0.09 | 1.12 | 0.00 | -2.22 | -6.46 | |
| 0.00 | 0.00 | 1.14 | 1.15 | 2.47 | 1.68 | 8.89 | -0.17 | 0.42 | 1.58 | 3.13 | 33.57 | |
| Net Cash Flow | 0.00 | 0.00 | -0.15 | -0.03 | 1.14 | -0.89 | 2.73 | -2.76 | 0.20 | 0.03 | 0.15 | 7.67 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 208.57 | 149.74 | 40.00 | 17.80 | 33.42 | 3.08 | 7.68 | 72.50 | 264.22 | 279.24 | ||
| Inventory Days | 851.67 | 214.71 | 62.93 | 124.43 | 112.54 | 114.68 | 16.50 | 2,920.00 | 200.39 | 143.54 | 216.24 | |
| Days Payable | 182.50 | 118.09 | 132.16 | 82.95 | 63.87 | 48.09 | 115.48 | 8,030.00 | 76.34 | 49.21 | 10.57 | |
| Cash Conversion Cycle | 877.74 | 246.36 | -29.22 | 59.28 | 82.08 | 69.67 | -91.30 | 196.55 | 358.54 | 484.91 | ||
| Working Capital Days | 521.43 | 149.74 | -70.00 | 53.41 | 102.82 | 40.04 | -115.26 | 300.00 | 119.85 | 734.31 | ||
| ROCE % | -460.71% | -360.00% | -1,168.00% | -180.95% | -200.00% | -135.55% | -81.26% | -43.71% | -92.65% | -56.13% | 5.85% |
Documents
Announcements
-
Submission Of Disclosure Under Regulation 7(2) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015
1 Dec - Promoter/Promoter group acquired shares on November 27, 2025; disclosure submitted under SEBI Reg 7(2).
-
Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday, November 25, 2025
25 Nov - Allotment of 250,000 equity shares at Rs54 each (Rs1.35 crore) on Nov 25, 2025 to two investors.
-
Intimation Regarding Receipt Of In-Principle Approval Of BSE Limited For Issue Of Equity Shares To Promotor And Non-Promotor Category On A Preferential Basis.
15 Nov - BSE in-principle approval (14 Nov 2025) for preferential issue of 250,000 shares at ≥Rs54.
-
Intimation Regarding Applicability Of Disclosure Of Related Party Transactions Pursuant To SEBI Circular Dated November 11, 2024
13 Nov - Valencia to submit half-yearly related party transactions disclosure for period ended 30 Sep 2025.
-
Statement Of Deviation Or Variation Under Regulation 32 Of SEBI (LODR) Regulations, 2015 For The Half-Year Ended September, 2025.
13 Nov - No deviation; Rights Rs21.78Cr, Preferential/Warrants Rs32.07Cr fully utilised for H1 Sep 30, 2025.
Business Overview:[1][2]
VNL is a BSE Start Up Listed Corporate Company since January 2020. It is an applied biotechnology company focused on research, developing & marketing Ready to Drink nutraceuticals, Ready-to-Mix nutraceuticals (Ease Out Sachets) viz. AL Cans, Sachets, PET bottles, PET Cans, Tetra Pack, and Refreshment Mints etc. to prevent or manage lifestyle related diseases